Loading, please wait....jpg)
.jpg)
The Premier October 25, 2023 CE webinar will be held from 12 - 1 pm EDT. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
CLINICAL AND REGULATORY CONSIDERATIONS IN MEDICAL CANNABIS
SPEAKER: Christine Roussel, PharmD, BCOP, BCSCP, Senior Executive Director, Pharmacy, Laboratory and Medical Research, Doylestown Health, Doylestown, PA
ACPE Universal Activity Number 0122-0000-23-060-L03-P/T [0.1 CEU] [1 Contact Hr.] (Pharmacy Law CE)
Date: Oct 25, 2023 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Oct 25, 2023 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Oct 25, 2023
at 12:10 PM
Registration Closed
Objectives
- Describe key features of the endocannabinoid system & cannabis pharmacology, pharmacokinetics and formulations
- Discuss considerations in patient evaluation, dosage and therapeutic monitoring with a focus on recognition of potential drug interactions and adverse effects
- Explain the federal regulatory status of cannabis as a controlled substance
- Provide an overview of the new proposed USP cannabis monograph
- Review scenarios of inpatient management of medical cannabis patients and their products
Speaker(s)/Author(s)
|
Christine Roussel, PharmD, BCOP, BCSCP
|